Vancenase AQ en es it fr

Vancenase AQ Brand names, Vancenase AQ Analogs

Vancenase AQ Brand Names Mixture

  • none

Vancenase AQ Chemical_Formula

C28H37ClO7

Vancenase AQ RX_link

http://www.rxlist.com/cgi/generic2/qvar.htm

Vancenase AQ fda sheet

Vancenase_AQ FDA

Vancenase AQ msds (material safety sheet)

Vancenase AQ Synthesis Reference

U.S. Pat. 3,312,590 (1967)

Vancenase AQ Molecular Weight

521.042 g/mol

Vancenase AQ Melting Point

117-120oC

Vancenase AQ H2O Solubility

49.39 mg/L

Vancenase AQ State

Solid

Vancenase AQ LogP

3.795

Vancenase AQ Dosage Forms

Oral inhalation; Nasal inhalation; Nasal spray

Vancenase AQ Indication

For the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older

Vancenase AQ Pharmacology

Beclomethasone, a synthetic halogenated glucocorticoid with antiinflammatory and vasoconstrictive effects, is used for treating steroid-dependent asthma, allergic or nonallergic rhinitis, or recurrent nasal polyps.

Vancenase AQ Absorption

Mean peak plasma concentration was 88pg/ml at 0.5 hour

Vancenase AQ side effects and Toxicity

The acute toxicity of beclomethasone dipropionate is low. The only harmful effect that follows inhalation of large amounts of the drug over a short period of time is suppression of hypothalamic-pituitary-adrenal (HPA) function. Chronic: The excessive use of beclomethasone dipropionate over a long period could lead to adrenal suppression.

Vancenase AQ Patient Information

Vancenase AQ Organisms Affected

Humans and other mammals